As of 2026-02-06, the Intrinsic Value of Laboratory Corporation of America Holdings (LH) is 356.58 USD. This LH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 276.16 USD, the upside of Laboratory Corporation of America Holdings is 29.10%.
The range of the Intrinsic Value is 237.48 - 660.78 USD
Based on its market price of 276.16 USD and our intrinsic valuation, Laboratory Corporation of America Holdings (LH) is undervalued by 29.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 237.48 - 660.78 | 356.58 | 29.1% |
| DCF (Growth 10y) | 309.43 - 788.89 | 445.24 | 61.2% |
| DCF (EBITDA 5y) | 262.17 - 370.90 | 320.41 | 16.0% |
| DCF (EBITDA 10y) | 324.63 - 470.26 | 398.09 | 44.2% |
| Fair Value | 219.98 - 219.98 | 219.98 | -20.34% |
| P/E | 233.64 - 269.66 | 253.03 | -8.4% |
| EV/EBITDA | 168.82 - 272.89 | 229.94 | -16.7% |
| EPV | 156.97 - 236.94 | 196.96 | -28.7% |
| DDM - Stable | 92.88 - 279.36 | 186.12 | -32.6% |
| DDM - Multi | 193.79 - 444.09 | 268.82 | -2.7% |
| Market Cap (mil) | 22,893.66 |
| Beta | 0.37 |
| Outstanding shares (mil) | 82.90 |
| Enterprise Value (mil) | 27,946.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.55% |
| Cost of Debt | 4.54% |
| WACC | 6.63% |